Mikey Mass

Mikey Mass has a wide range of work experience in the field of biosciences and engineering. In 2021, they began working as a Scientist and Associate Scientist at 3T Biosciences. In 2020, they were a Senior Research Associate and Research Associate II at PACT Pharma, where they significantly impacted the company's IP portfolio with their efforts contributing to seven patent applications in less than one year. In 2018, they were a Graduate Researcher at the Johns Hopkins Whiting School of Engineering, where they investigated ligand-receptor interactions of tumor necrosis factor (TNF) family proteins using yeast surface display. Also in 2018, they were a Graduate Researcher at the Johns Hopkins University School of Medicine, where they focused on enrichment and expansion (E&E) of antigen specific CD4+ T cell clonotypes for adoptive cell transfer. In 2016, they were an Undergraduate Researcher at San Francisco State University, where they engineered and characterized an enhanced expression vector using a strategy of promoter hybridization.

Mikey Mass has a Master of Science in Engineering in Biomedical Engineering from Johns Hopkins Whiting School of Engineering, with a concentration in Regenerative and Immune Engineering, obtained in 2019. Mikey also has a Bachelor of Science in Biology from San Francisco State University, with a concentration in Botany, obtained in 2017.